246 related articles for article (PubMed ID: 17524936)
1. Pharmacokinetics, efficacy, and safety of Iminoral compared with Neoral in healthy volunteers and renal transplant recipients.
Sayyah M; Argani H; Pourmand GR; Amini H; Ahmadiani A
Transplant Proc; 2007 May; 39(4):1214-8. PubMed ID: 17524936
[TBL] [Abstract][Full Text] [Related]
2. A bioavailability study of cyclosporine: comparison of Neoral versus Cysporin in stable heart transplant recipients.
Leet A; Richardson M; Senior JA; Funston R; Skiba M; Bailey M; Krum H
J Heart Lung Transplant; 2009 Sep; 28(9):894-8. PubMed ID: 19716041
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
Qazi YA; Forrest A; Tornatore K; Venuto RC
Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
[TBL] [Abstract][Full Text] [Related]
4. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring.
Sharma A; Shekhar C; Heer M; Minz M
Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients.
Hibberd AD; Trevillian PR; Roger SD; Wlodarczyk JH; Stein AM; Bohringer EG; Milson-Hawke SM
Transplantation; 2006 Mar; 81(5):711-7. PubMed ID: 16534473
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of equoral versus neoral in stable renal transplant patients: a multinational multicenter study.
Masri MA; Haberal M; Rizvi A; Stephan A; Bilgin N; Naqvi A; Barbari A; Kamel G; Zafar N; Emiroğlu R; Colak T; Manzoor K; Matha V; Kamarad V; Rizk S; Itany AR; Shehedeh I
Transplant Proc; 2004; 36(1):80-3. PubMed ID: 15013306
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
White M; Pelletier GB; Tan A; Jesina C; Carrier M
J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic equivalence and mg:mg switch ability of a generic cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients maintained on Sandimmun Neoral.
Al Wakeel JS; Shaheen FA; Mathew MC; Abouzeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
Transplant Proc; 2008 Sep; 40(7):2252-7. PubMed ID: 18790206
[TBL] [Abstract][Full Text] [Related]
10. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
Zhang Y; Zhang XD; Wang Y
Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
[TBL] [Abstract][Full Text] [Related]
12. Safe conversion to cicloral, a generic cylosporine, in both stable and de novo renal transplant recipients.
Kahn D; Muller E; Pascoe M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):426-32. PubMed ID: 20427863
[TBL] [Abstract][Full Text] [Related]
13. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
Takatsuki M; Chen CL; Chen YS; Wang CC; Lin CC; Yang CH; Yong CC; Liu YW
Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
[TBL] [Abstract][Full Text] [Related]
14. Effect of orange and tangerine juice on cyclosporine levels in renal transplant recipients.
Sorkhi H; Oliaei F; Moghadamnia AA; Pouramin M; Firoozjahi AR
Transplant Proc; 2007 May; 39(4):1228-30. PubMed ID: 17524940
[TBL] [Abstract][Full Text] [Related]
15. Switchability of neoral and equoral according to Food and Drug Administration rules and regulations.
Masri MA; Haberal M; Rizvi A; Stephan A; Bilgin N; Naqvi A; Barbari A; Kamel G; Zafar N; Emiroğlu R; Colak T; Manzoor K; Matha V; Kamarad V; Rost M; Rizk S; Hazime A; Perlik F
Transplant Proc; 2005 Sep; 37(7):2988-93. PubMed ID: 16213282
[TBL] [Abstract][Full Text] [Related]
16. No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem.
Aros CA; Ardiles LG; Schneider HO; Flores CA; Alruiz PA; Jerez VR; Mezzano SA
Transplant Proc; 2005 Oct; 37(8):3364-6. PubMed ID: 16298597
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
Dotti G; Gaspari F; Caruso R; Perico N; Remuzzi G; Barbui T; Rambaldi A
Haematologica; 2001 Mar; 86(3):311-5. PubMed ID: 11255279
[TBL] [Abstract][Full Text] [Related]
18. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
van Mourik ID; Thomson M; Kelly DA
Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
[TBL] [Abstract][Full Text] [Related]
20. Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation.
Roza A; Tomlanovich S; Merion R; Pollak R; Wright F; Rajagopalan P; Pruett T; Scandling J; Ryan J; Awni W; Schweitzer S; Greco R; Lam W; Nabulsi A; Hoffman R
Transplantation; 2002 Oct; 74(7):1013-7. PubMed ID: 12394847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
